Subunit b, the peripheral stalk of bacterial F 1 F o ATP synthases, is composed of a membrane-spanning and a soluble part. The soluble part is divided into tether, dimerization, and ␦-binding domains. The first solution structure of b30-82, including the tether region and part of the dimerization domain, has been solved by nuclear magnetic resonance, revealing an ␣-helix between residues 39 and 72. In the solution structure, b30-82 has a length of 48.07 Å. The surface charge distribution of b30-82 shows one side with a hydrophobic surface pattern, formed by alanine residues. Alanine residues 61, 68, 70, and 72 were replaced by single cysteines in the soluble part of subunit b, b22-156. The cysteines at positions 61, 68, and 72 showed disulfide formation. In contrast, no cross-link could be formed for the A70C mutant. The patterns of disulfide bonding, together with the circular dichroism spectroscopy data, are indicative of an adjacent arrangement of residues 61, 68, and 72 in both ␣-helices in b22-156.
domain. The structure of the synthesized 33-residue peptide comprising the N-terminal membrane-spanning region has been solved by 1 H NMR, showing an ␣-helical feature (14) . The crystallographic structure of the major part of the dimerization domain, b62-122, revealed an ␣-helix with a length of 9.0 nm (12) . Most recently, the NMR solution structure of the very C-terminal segment, b140-156, which interacts with the C terminus of subunit ␦ (␦91-177), has been determined by NMR spectroscopy (26) . This molecule adopts a stable helix formation in solution with a flexible tail between amino acid residues 140 and 145. SAXS (26) and analytical ultracentrifuge studies have indicated that the soluble domain of subunit b (b21-156, b22-156) is dimeric in solution (12) . So far, no high-resolution structure of the tether domain, including residues 25 to 52, or the N-terminal segment of the dimerization domain, which is formed by residues 53 to 122, is available (14) .
Here, we have turned our attention to the production and purification of residues 30 to 82 of subunit b (b30-82) from E. coli F 1 F o ATP synthase, which forms the remaining unsolved structural segment of subunit b. The structural features of this segment have been determined in solution using NMR spectroscopy. The introduction of a cysteine residue into b22-156 at four positions resulted in different intersubunit disulfide patterns, giving insight into the proximity of the residues.
MATERIALS AND METHODS
Abbreviations. The abbreviations used in this article are as follows: 2D, 2-dimensional; 3D, 3-dimensional; CD, circular dichroism; DSS, 2,2-dimethyl-2-silapentane-5-sulfonate; DTT, dithiothreitol; HSQC, heteronuclear single quantum coherence; IPTG, isopropyl-␤-D-thiogalactoside; NMR, nuclear magnetic resonance; NOE, nuclear Overhauser effect; NOESY, NOE spectroscopy; NTA, nitrilotriacetic acid; PAGE, polyacrylamide gel electrophoresis; PFG, pulsedfield gradient; SAXS, small-angle X-ray scattering; R 1 , longitudinal relaxation time; R 2 , transverse relaxation time; RMSD, root mean square deviation; SDS, sodium dodecyl sulfate, TOCSY, total correlation spectroscopy; TPPI, timeproportional phase incrementation. Cloning, production, and protein purification. In order to produce the truncated b subunit, b30-82, forward primer 5Ј-GCC ATC CAT GGC AGC AAT C-3Ј and reverse primer 5Ј-CTG GAG CTC TCA CTT GTT CGC CTG-3Ј were designed. The atpF-atpH-containing plasmid pPR1, which codes for the soluble domain of subunit b (b22-156) and subunit ␦ (26), was used as the template for PCR. PCR products incorporating NcoI and SacI restriction sites were digested and ligated to the pET9d1 vector with or without His 3 (19 ), for about 6 h at 37°C, until an optical density at 600 nm of 0.6 to 0.7 was reached. To induce production of proteins, cultures were supplemented with IPTG to a final concentration of 1 mM. Following incubation for another 4 h at 30°C, the cells were harvested at 10,000 ϫ g for 15 min at 4°C. Subsequently, they were lysed on ice by sonication three times, for 1 min each time, in buffer A (50 mM Tris-HCl [pH 7.5], 250 mM NaCl, and 1 mM phenylmethylsulfonyl fluoride). The lysate was cleared by centrifugation at 10,000 ϫ g for 35 min. The supernatant was filtered (pore size, 0.45 m; Millipore) and passed over a 2-ml Ni 2ϩ -NTA resin column to isolate the proteins. The His-tagged protein was allowed to bind to the matrix for 2 h at 4°C and was eluted with an imidazole gradient (15 to 300 mM) in buffer A. Fractions containing His 3 -tagged b30-82 were identified by SDS-PAGE (24), pooled, and subsequently applied to an ion-exchange column (Resource Q; 6 ml; GE Healthcare). The proteins were concentrated using Centricon YM-3 (molecular mass cutoff, 3 kDa) spin concentrators (Millipore). The purity of all protein samples was analyzed by SDS-PAGE (24) . SDS gels were stained with Coomassie brilliant blue G250. Protein concentrations were determined by the bicinchoninic acid assay (Pierce, Rockford, IL).
Biochemicals. Pfu
The A61C, A68C, A70C, and A72C single mutants of subunit b22-156 were generated by an overlap extension PCR method (21) using the atpF-atpH-containing plasmid pPR1 as a template (26) . In two PCRs, mutations were introduced by internal primers: A61C internal forward, 5Ј-CTG AGC AGA TAA AGT GCG AGG CAA T-3Ј; A61C internal reverse, 5Ј-ATT GCC TCG CAC TTT ATC TGC TCA G-3Ј; A68C internal forward, 5Ј-CAG ATA AAG GCA GAG TGT ATT GAA GAA GCA-3Ј; A68C internal reverse, 5Ј-TGC TTC TTC AAT ACA CTC TGC CTT TAT CTG-3Ј; A70C internal forward, 5Ј-AAG AAA GCG AAA TGC GAA GCC CA-3Ј; A70C internal reverse, 5Ј-TG GGC TTC GCA TTT CGC TTT CTT-3Ј; A72C internal forward, 5Ј-G AAA GCG GAA TGC CAG GTA ATC AT-3Ј; A72C internal reverse, 5Ј-AT GAT TAC CTG GCA TTC CGC TTT C-3Ј. Mutated gene constructs of b22-156 were finally amplified using flanking primers 5Ј-CCT GTT CAC CAT GGC TTG CA-3Ј (forward primer a) and 5Ј-TTC GAG CTC TTA AGA CTG CAA GAC GTC-3Ј (reverse primer d). Following digestion with NcoI and SacI, the PCR product was ligated into the pET9d-His 3 vector. The mutations were verified by DNA sequencing. Proteins were produced from these mutants as recently described for b22-156 (26) .
CD spectroscopy. Steady-state CD spectra were measured in the far-UV-light range (180 to 260 nm) using a Chirascan spectrometer (Applied Photophysics). Spectra were collected in a 60-l quartz cell (Hellma) with a path length of 0.1 mm at 20°C and a step resolution of 1 nm. The readings were averages of 2 s at each wavelength, and the recorded millidegree values were averages of three determinations for each sample. CD spectroscopy of b30-82 and the b22-156 mutant proteins (1.0 mg/ml) was performed in a buffer consisting of 50 mM Tris-HCl (pH 7.5) and 250 mM NaCl. The spectrum for the buffer was subtracted from the spectrum for the protein. CD values were converted to mean residue molar ellipticity (⍜) in units of degrees times square centimeters per decimole per amino acid using Chirascan software (version 1.2; Applied Photophysics). This baseline corrected spectrum was used as the input for computer methods to obtain predictions of secondary structure. The CD spectra were analyzed as described recently (26) .
Cross-link formation of the cysteine mutants. The b22-156 A61C, A68C, A70C, and A72C mutants were supplemented with 10 M CuCl 2 as a zero-length cross-linker for 20 min on a sample rotator at 4°C. The reaction was stopped by addition of 1 mM EDTA. Samples were dissolved in DTT-free dissociation buffer and were applied to an SDS-polyacrylamide gel as described above.
NMR data collection and processing. 3 . NMR experiments were performed at 15°C on a Bruker Avance 600-MHz spectrometer using a triplechannel cryoprobe equipped with gradient accessories. The experiments recorded on the N chemical shifts were referenced indirectly to DSS. All the NMR spectra were processed either using NMRPipe/NMRDraw (10) or TopSpin, version 2.1, the built-in software of the Bruker Avance spectrometer. Peak picking and data analysis of the Fourier-transformed spectra were performed with the SPARKY program (22) .
Collection of structural constraints and structure calculations. The structure calculations were performed starting from Met 30 at the N terminus, located after Pro 29 . The His residues of the His tag at the N terminus were ignored. Distance constraints for the structure calculations were collected from 3D 15 N-edited NOESY-HSQC by manually and automatically assigned NOEs using CYANA, version 3.0 (20) . Dihedral angle restraints were calculated from C␣ and C␤ chemical shifts by using TALOS (9). Secondary structure was predicted from the chemical shift index (35) and NOE patterns. Seven cycles of automated NOESY assignment using the CYANA package, version 3.0, were performed. In the final CYANA cycle, NOESY cross peaks were assigned unambiguously, leading to 468 meaningful NOE distance restraints. Ten conformers of the monomeric b30-82 were calculated based on the dihedral angles and NOE restraints obtained. The MOLMOL program was used to visualize the result of the ensemble of minimized conformers (23) .
Diffusion coefficient measurements. The translational diffusion rates were measured by monitoring 1D 1 H signal decay due to molecular diffusion in the z-direction of the sample using PFGs (18, 33) at variable concentrations of b30-82. In each experiment, the PFG strength was linearly increased from 2 to 95 G/cm, with a translational diffusion delay of 200 ms and total encoding and decoding gradient durations of 5 ms. The diffusion rates were estimated using TopSpin (Bruker BioSpin).
RESULTS
Production and purification of b30-82. SDS-PAGE of the recombinant b30-82 that was produced, including the tether region and part of the dimerization domain of subunit b, revealed a prominent band of 6 kDa, which was found entirely within the soluble fraction. A Ni 2ϩ -NTA resin column and an imidazole gradient (15 to 300 mM) in a buffer consisting of 50 mM Tris-HCl (pH 7.5) and 250 mM NaCl was used to separate b30-82 from the main contaminating proteins. The protein eluting at 75 to 125 mM imidazole, b30-82, was collected and subsequently applied to an ion-exchange column (Resource Q). Analysis of the isolated protein by SDS-PAGE revealed the high purity of b30-82 (Fig. 1A) . The secondary structure of this subunit was determined from CD spectra, measured between 185 and 260 nm (Fig. 1B) . The minima at 222 and 208 nm and the maximum at 192 nm indicate the presence of ␣-helical structures in the protein, and the secondary structure was calculated to be 71% ␣-helix and 28% random coil. The ratio of the molar ellipticity at 222 nm to that at 208 nm (⍜ 222 /⍜ 208 ) was determined to be 0.81. VOL. 191, 2009 STRUCTURAL TRAITS OF b30-82 7539
Solution structure of the N-terminal domain of b30-82. To determine the first solution structure of the tether domain, b30-82 was analyzed by NMR spectroscopy. Well-dispersed cross peaks appear in the 2D 1 H-15 N HSQC spectrum, suggesting that the protein is folded (Fig. 2A) (Fig. 2B) . The positive carbon secondary shifts of residues 39 to 72 demonstrate the presence of a helical structure in this region. The 3D structure of subunit b30-82 was calculated based on a total of 464 NMR-derived distance restraints, of which 142 were intraresidual, 132 were sequential, and 73 were medium range. Hydrogen bond constraints were determined from the ␣-helical NOE pattern observed in the 3D
15 N-edited NOESY-HSQC spectrum and were introduced at the end of structural calculations. Ribbon diagrams of the NMR solution structure of b30-82 and a representation of the molecular surface with the electrostatic potential of the peptide are shown in Fig. 3A to D. Figure 3A represents an overlay of the 10 lowestenergy structures of b30-82; the statistics are given in Table 1 . b30-82 adopts a regular ␣-helical conformation extending from residues 39 to 72, giving rise to a rod-like molecule. This might lead to an anisotropic tumbling motion, resulting in a broadening of NOESY peaks. However, since b30-82 is monomeric under the conditions used, more than 95% of backbone assignments were made, and all NOESY cross peaks have been assigned for the helical regions of this protein. The structures have overall RMSDs of 0.359 Å for backbone atoms and 0.964 Å for all heavy atoms in the helical regions (residues 39 to 72) of the 3D structures of the protein. All these structures have energies lower than 4 kcal ⅐ mol Ϫ1 , no NOE violations greater than 0.5 Å, and no dihedral angle violations greater than 5°. Analysis of the Ramachandran plots shows 83.9% of residues in the most favored regions and 16.1% in the additionally allowed regions. Statistics on the structure calculation are presented in Table 1 . In the solution structure, b30-82 has a length of 48.07 Å excluding the unstructured regions in the N (residues 30 to 39) and C (residues 73 to 82) termini.
Translational diffusion rates of b30-82. Since b30-82 includes a segment of the proposed dimerization domain (b53-122), the diffusion coefficient of b30-82 was measured as a function of protein concentration. As shown in Fig. 4 , the decrease in experimentally determined diffusion rates with increasing protein concentrations suggests dimer formation, assuming that the exchange between monomers and dimers is fast on the diffusion time scale. The corresponding dimer dissociation constant for b30-82 was estimated, by direct fit of translation diffusion rates as a function of concentration, to be Cross-link formation in cysteine mutants of b30-82. The solution structure of b30-82 shows a slightly twisted strip of hydrophobic alanine residues consisting of residues Ala 61 , Ala 68 , and Ala 72 (Fig. 3B and D) . To analyze the proximity of alanine residues of the first and second ␣-helices of the dimeric b30-82, Ala 61 , Ala 68 , and Ala 72 were each separately replaced by a cysteine residue, generating the A61C, A68C, and A72C single mutants, respectively, of the soluble and monodisperse subunit b domain b22-156 (26) . All three mutant proteins could be isolated in large amounts and at high purity (Fig. 5A) . CD spectroscopy revealed that the mutant proteins of b22-156 are 76% Ϯ 2% ␣-helical, a structure comparable to that of wild-type b22-156 (26) . Figure 5B shows CD spectra of the b22-156 A61C and A68C mutants, with ⍜ 222 /⍜ 208 ratios of 0.93 and 0.89, respectively, indicating an increased coiled-coil arrangement relative to that of b30-82 and a slight effect of alanine-to-cysteine mutation in the secondary structures of the mutant proteins. Cross-link formation in the presence of CuCl 2 (10 M) is shown in Fig. 5C (lanes 1, 2, and 4) , revealing that a significant amount of dimer formation could be generated for all three mutants analyzed. In contrast, when Ala 70 , located opposite Ala 72 (Fig. 3D ) in the helix, was replaced with a cysteine, no significant disulfide formation could be detected under the conditions used (Fig. 5C, lane 3) .
DISCUSSION
The shape of the hydrated cytoplasmic b22-156 sequence of the stalk subunit b of E. coli F 1 F o ATP synthase, determined by solution X-ray scattering, revealed that the protein is dimeric and an elongated particle of 16.2 Ϯ 0.3 nm (26) . b22-156 is described by a three-domain model, including the C-terminal ␦-binding domain, the dimerization domain, and the tether domain (15) . The tether domain, formed by residues 23 to 52, joins the membrane region (residues 1 to 22) to the beginning of the sequence essential for dimerization (residues 53 to 122). The structure of the synthesized 33-residue peptide consisting of the N-terminal membrane-spanning region shows an ␣-helical feature (14) . The crystallographic structure of the major part of the dimerization domain, b62-122, revealed an ␣-helix with a length of 9.0 nm (12) . Most recently, the NMR solution structure of the very C-terminal segment, b140-156, which interacts with the C terminus of subunit ␦ (␦91-177), has been determined; it adopts a stable helix formation in solution, with a flexible linker between amino acids 140 and 145 (26) . The NMR solution structure of b30-82 leads to a more complete understanding of the structural puzzle of the peripheral stalk and provides insight into a segment which was the least defined in subunit b. The crystallographic structure of b62-122 and the NMR structure of b30-82 are superimposed well in the overlapping region, including residues 62 to 72, with an RMSD value of 0.4387 (Fig. 6A) , demonstrating that b30-82 is a structural continuum of b62-122. When positioned inside the sphere of the low-resolution solution structure of the dimeric b22-156, the three monomeric structures of b62-122 (12), b30-82, and b140-156 (26) were accommodated very well (Fig. 6C) . In addition, the structural model of the fitted monomeric NMR and crystallographic structures of b1-33, b30-82, b62-122, and b140-156 (Fig. 6A) reveals that E. coli subunit b forms a single unbroken curved ␣-helix (excluding residues 35 to 38, not defined so far), which appears to be a relatively inflexible structure, a phenomenon described for subunit b of the mitochondrial F 1 F o ATP synthase (13) . This is also in line with mutation studies of the dimerization domain, demonstrating that substitutions affect the enzyme in assembly and/or enzyme function (8, 27) . However, deletions and extensions in the C-terminal end of the tether domain and the N-terminal region of the dimerization domain did not alter the assembly or function of the enzyme (4) . These data implied a rather flexible, rope-like feature of the bacterial b subunit, giving this subunit the possible role of an elastic peripheral stalk for transient storage of energy between steps in the rotary motion of the complex (7). The structure of the E. coli b subunit that is now available should enable the proposed elastic deformation to be measured.
As demonstrated in Fig. 6B , residues Ala 32 , Ala 45 , Ala 50 , Ala 57 , Ala 61 , Ala 68 , and Ala 72 form a hydrophobic surface in the tether domain and the N-terminal segment of the dimerization domain. The cross-link formation of the b22-156 A61C, A68C, and A72C mutants confirm that these residues are located at one side of the helix and that the two cysteines in positions 61 and 61Ј, 68 and 68Ј, and 72 and 72Ј, respectively, of the first and second helices are in close proximity (Fig. 5C ). In contrast, only traces of a homodimer can be seen for the cysteine in position 70, reflecting the location of residue 70 at the opposite sides of the two helices (Fig. 3D) . Since the CD spectrum of b30-82 shows no strong coiled-coil formation, the two helices of the tether domain are predicted to be adjacent to each other, as proposed for the N-terminal domain of b1-34, in which aromatic residues form the hydrophobic interaction surface (14) and are located on the same surface side as residues Ala 32 , Ala 45 , Ala 50 , Ala 57 , Ala 61 , Ala 68 , and Ala 72 (Fig.  6B) . Recently, T62C mutation and cross-linking experiments with this mutant have been performed using the entire E. coli F 1 F o ATP synthase, and no disulfide formation could be detected in the holoenzyme (29) . Figure 6A and D show that residue Thr 62 is oriented about 120°away from the site of the hydrophobic surface, formed by residues Ala 61 , Ala 68 , and Ala 72 , supporting the absence of disulfide bond formation in the E. coli F 1 F o ATP synthase T62C mutant (29) . The structure of b30-82 also indicates that Gln 64 is positioned at the exposed side of the helix, which has been used for binding of the donor in single-molecule fluorescence resonance energy transfer during ATP hydrolysis and synthesis of E. coli F 1 F o ATP synthase (16, 29) .
In summary, the data presented here demonstrate that the tether domain (b30-82) of E. coli subunit b exists mainly as an ␣-helix in solution. Fitting of the existing high-resolution structures of the N-terminal, tether, dimerization, and very C-ter- (12), b30-82 (green) (pdb 2KHK), and b140-156 (yellow) (26) were superimposed on the low-resolution structure of the dimeric b22-156, derived from solution X-ray scattering data (26) . (D) Structures of b30-82 (green) and the N-terminal segment of b62-122 (orange) (pdb 1L2P) (12) 
